Chemotherapy Advances with Dr. N. Khushalani, Dr. J. Prah and D. Thompson

PrintE-mailPDF
Sunday, August 21, 2011

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

audio/mpeg iconDownload File
Chemotherapy Advances with Dr. N. Khushalani, Dr. J. Prah and D. Thompson

Nikhil Khushalani, MD, Soft Tissue and Melanoma Section Chief and Director of the IL-2 Program, and Joseph Prah, MD, former Assistant Professor in the Department of Medicine, discuss recent advances in cancer chemotherapeutics, including targeted therapies, FDA approval for vemurafenib and current/upcoming clinical trials. Joining the conversation is melanoma survivor Drew Thompson.

Cancer Talk Blog
Understanding Brain Tumors: The Basics
May is National Brain Tumor Awareness Month. To help you begin to understand this complex group of tumors, we have compiled some of the key facts, statistics and information below. Learn about the Neuro-oncology Center at Roswell Park or consult the links and sources below for more information. Brain Tumor Facts and Figures
Read more

Ask A Question

Do you have a cancer question you’d like RPCI cancer experts to address? Submit a topic for consideration.

New to RSS? Learn More

close